Learn About Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Local Doctors?
Elite
Elite
 
 
 
 
Learn about our expert tiers
Learn more
Elite
What are the Latest Advances for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)?
Usefulness of bilateral mucoplasty plus reboot surgery in severe type-2 chronic rhinosinusitis with nasal polyps.
The development of a personalized approach in the treatment of chronic rhinosinusitis with nasal polyps.
Tired of the same old research?
Check Latest Advances
The Role of Omalizumab in NSAID-Exacerbated Respiratory Disease: A Narrative Review.
What are the latest Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Clinical Trials?
A Randomized, Double Blind, Placebo-controlled, Dose Escalation Phase 1b/2a Study to Evaluate the Safety, Tolerability, PK, PD, Immunogenicity and Preliminary Efficacy of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps

Summary: This is a multi-center, randomized, double blind, placebo-controlled, dose escalation study to evaluate the safety, tolerability, PK, PD, immunogenicity and preliminary efficacy of CM326 in patients with chronic rhinosinusitis with nasal polyps. The study consists of 3 periods, a up-to-4-week Screening Period, a 12-week Treatment Period and a 12-week Safety Follow-up Period.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Peripheral Eosinophils Phenotypes in Airway Inflammatory Diseases: Towards Proper Clustering and Therapeutic Targeting

Summary: Asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) are frequently described as unified airway inflammatory diseases. Both heavily impacts quality of life with substantial productivity loss. They share the same pathophysiologic pattern based upon proTh2 immune response with blood eosinophils recruitment. Eosinophils are the major actor of persistent mucosal inflammation by promoting their...